Olinger Margaret insider trades
Olinger Margaret has filed 6 Form 4s with the SEC that we hold, all for Amylyx Pharmaceuticals, Inc. (AMLX), as Chief Commercial Officer. Across all of them we count 1 purchase worth $130.0K and 2 sales worth $87.2K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 6,842 shares of Amylyx Pharmaceuticals, Inc. worth $130.0K, dated 2022-01-06. The first filing on our record is dated 2022-01-10 and the latest 2023-12-29.
Amylyx Pharmaceuticals, Inc. (AMLX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-01-06 | P, purchase reported on Form 4 | 6,842 | $130.0K | 2022-01-10 |
| 2023-01-06 | S, sale reported on Form 4 | 1,660 | $59.9K | 2023-01-10 |
| 2023-01-06 | S, sale reported on Form 4 | 743 | $27.3K | 2023-01-10 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1898725) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms